Skip to main content
. 2026 Feb 18;12(1):e006409. doi: 10.1136/rmdopen-2025-006409

Table 2. Descriptive analysis of CoR familial Mediterranean fever patients (n=118).

Characteristics of CoR patients All CoR (n=118) Paediatric diagnostic
(n=85)
Adult diagnostic (n=33) P value paediatric versus adult
Female, n (%) 67 (56.8) 34 (40) 17 (51.52) 0.354
Age at symptom onset, mean (SD) (years) 4.93 (4.81) 3.84 (3.54) 7.74 (6.41) <0.001
Age at first symptoms ≤3 years, n (%) 52 (44.1) 46 (54.12) 6 (18.18) <0.001
Age at diagnosis, mean (SD) (years) 14.14 (13.87) 6.78 (4.64) 33.08 (11.81)
Attack duration, mean (SD) (days) 2.83 (1.2) 2.65 (1.01) 3.29 (1.53) 0.008
Parental consanguinity, n (%) (data availability) 13 (12.9) (101/118) 9 (12) 4 (15.38) 0.736
Homozygosity or compound heterozygosity for exon 10 MEFV variants, n (%) 118 (100%) 82 (100) 34 (100)
Frequency of attacks ≥1 per month, n (%) 91 (77.1) 71 (83.53) 20 (60.61) 0.013
Clinical findings before diagnosis, n (%)
      Fever
      ELE
      Arthralgia
      Arthritis
      Abdominal pain
      Chest pain
101 (85.6)
56 (47.5)
95 (80.5)
48 (40.7)
113 (95.8)
51 (43.2)
74 (87.0)
41 (48.2)
67 (78.8)
35 (41.2)
81 (95.3)
40 (47.1)
27 (81.8)
15 (45.5)
28 (84.9)
13 (39.4)
33 (97)
11 (33)
0.56
0.947
0.607
>0.999
>0.999
0.253
TURPAID score, mean (SD) 2.73 (0.69) 2.84 (0.692) 2.45 (0.63) 0.011
Patients with TURPAID score ≥2, n (%) 111 (94.1) 82 (96.47) 29 (87.88) 0.095

Variables in bold are statistically significant.

CoR, colchicine-resistant; ELE, erysipela-like erythema; TURPAID, Turkish Paediatric Autoinflammatory Diseases.